Maximum quantity allowed is 999
Please select the quantity
CAS RN: 16676-29-2 | Product Number: N1176
Naltrexone Hydrochloride
Purity: >98.0%(GC)(HPLC)
Synonyms:
- Trexan
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
250MG |
NT$7,200
|
1 | 5 | Contact Us | |
1G |
NT$21,640
|
1 | 10 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | N1176 |
Purity / Analysis Method | >98.0%(GC)(HPLC) |
Molecular Formula / Molecular Weight | C__2__0H__2__3NO__4·HCl = 377.87 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 16676-29-2 |
Reaxys Registry Number | 3580333 |
PubChem Substance ID | 468592499 |
MDL Number | MFCD00069324 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Water | max. 11.0 % |
Properties (reference)
Melting Point | 178 °C |
Solubility in water | Soluble |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | QD2160000 |
Transport Information:
H.S.code* | 2939.19-000 |
Application
Naltrexone Hydrochloride: A Long Acting Competitive Peripheral μ-Opioid Antagonist
Naltrexone hydrochloride, a long acting competitive peripheral μ-opioid antagonist, is a synthetic congener of opioid analgesics with little or no μ-opioid agonist properties.1) It is used for the treatment of opioid dependence and opioid-induced constipation, and is also used for alcohol dependence in US and EU.2,3) Recently, μ-opioid receptor is a potential target for cancer therapy because of its plausible role in tumor progression. Therefore, the μ-opioid antagonist naltrexone has received attention as a new anticancer agent with few side-effects (low-dose naltrexone, LDN).4,5) (The product is for research purpose only.)
References
- 1) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
- 2) Alteration of ethanol self-administration by naltrexone
- 3) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence (a review)
- 4) The opioid growth factor-opioid growth factor receptor axis: Homeostatic regulator of cell proliferation and its implications for health and disease (a review)
- 5) Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.